{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:44Z","timestamp":1786119104617,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Vancomycin-resistant enterococci are important pathogens for healthcare-associated infections. Although linezolid is bacteriostatic and daptomycin is rapidly bactericidal against vancomycin-resistant enterococci in vitro, it is not clear whether they differ in their effect on bacterial clearance in patients with vancomycin-resistant enterococci bloodstream infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Prospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Two university hospitals and research laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Patients with vancomycin-resistant enterococci bloodstream infection proven by blood cultures were prospectively enrolled from January 2010 to July 2015.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Sequential blood samples were collected. Real-time quantitative polymerase chain reaction was used to monitor bacterial loads.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      One hundred eight patients with vancomycin-resistant enterococci bloodstream infection were enrolled. Quantitative polymerase chain reaction assays were performed on 465 blood isolates. We found this method to be closely correlated with colony-forming units and more sensitive than culture. Sixty-three patients (58.3%) received \u201cconventional dose\u201d daptomycin (6\u20139\u2009mg\/kg), 15 (13.9%) received high-dose daptomycin (\u2265 9\u2009mg\/kg), and 30 (27.8%) were treated with linezolid (600\u2009mg every 12 hr) as sole agents. The initial mean bacterial load was 1.03 log\n                      <jats:sub>10<\/jats:sub>\n                      copies\/mL and unrelated to survival. Survivors had a more rapid early bacterial clearance than nonsurvivors (\u0394 log\n                      <jats:sub>10<\/jats:sub>\n                      copies\/mL\/d; \u20130.16 vs 0.31;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.02). Multivariable logistic regression showed that a slower early bacterial clearance independently predicted increased mortality (odds ratio, 3.21; 95% CI, 1.03\u201310.02;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.045). Conventional dose daptomycin was associated with a significantly slower rate of bacterial clearance than high-dose daptomycin (\u0394 log\n                      <jats:sub>10<\/jats:sub>\n                      copies\/mL\/d; \u20130.04 vs \u20130.41;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and linezolid (\u20130.04 vs \u20130.56;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.043).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We found that survivors of vancomycin-resistant enterococci bloodstream infection had a significantly more rapid early bacterial clearance by quantitative polymerase chain reaction than nonsurvivors. High-dose daptomycin and linezolid were associated with more rapid bacterial clearance than conventional dose daptomycin. These results support recommendations that conventional dose daptomycin not be used for the treatment of patients with vancomycin-resistant enterococci bloodstream infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000003264","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T15:11:31Z","timestamp":1530198691000},"page":"1634-1642","source":"Crossref","is-referenced-by-count":18,"title":["Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance*"],"prefix":"10.1097","volume":"46","author":[{"given":"Yu-Chung","family":"Chuang","sequence":"first","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan."},{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Economics, National Chengchi University, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America.","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/archinte.163.16.1905","article-title":"Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.","volume":"163","author":"Mart\u00ednez","year":"2003","journal-title":"Arch Intern Med"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1086\/339211","article-title":"Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center.","volume":"34","author":"Lodise","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"VRE and VSE bacteremia outcomes in the era of effective VRE therapy: A systematic review and meta-analysis.","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis.","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/14656560902811811","article-title":"Therapeutic options for infections due to vancomycin-resistant enterococci.","volume":"10","author":"Wang","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","article-title":"Linezolid: The first oxazolidinone antimicrobial.","volume":"138","author":"Moellering","year":"2003","journal-title":"Ann Intern Med"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.","volume":"38","author":"Pankey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R10-20230728","first-page":"557","article-title":"Mortality associated with enterococcal bacteremia.","volume":"160","author":"Bryan","year":"1985","journal-title":"Surg Gynecol Obstet"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: A national cohort study of veterans affairs patients.","volume":"61","author":"Britt","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01289-13","article-title":"Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.","volume":"58","author":"Balli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12879-014-0687-9","article-title":"Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: Systematic review and meta-analysis.","volume":"14","author":"Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(04)01205-8","article-title":"New developments in the diagnosis of bloodstream infections.","volume":"4","author":"Peters","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.19.1.165-256.2006","article-title":"Real-time PCR in clinical microbiology: Applications for routine laboratory testing.","volume":"19","author":"Espy","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/JCM.01197-08","article-title":"High levels of mecA DNA detected by a quantitative real-time PCR assay are associated with mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.","volume":"47","author":"Ho","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/adc.86.1.44","article-title":"Meningococcal bacterial DNA load at presentation correlates with disease severity.","volume":"86","author":"Hackett","year":"2002","journal-title":"Arch Dis Child"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"e14133","DOI":"10.1371\/journal.pone.0014133","article-title":"High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: Implication for pathogenesis and evaluation of therapy.","volume":"5","author":"Chuang","year":"2010","journal-title":"PLoS One"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/CCM.0b013e3182515190","article-title":"Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia.","volume":"40","author":"Chuang","year":"2012","journal-title":"Crit Care Med"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1128\/AAC.49.11.4784-4786.2005","article-title":"High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora.","volume":"49","author":"Domingo","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","article-title":"Guidelines for the prevention of intravascular catheter-related infections.","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: A commentary.","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"890.e1","DOI":"10.1016\/j.cmi.2016.07.018","article-title":"Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: Implications of daptomycin dose.","volume":"22","author":"Chuang","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cix024","article-title":"Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia.","volume":"64","author":"Chuang","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/cid\/ciw815","article-title":"Comparative effectiveness and safety of standard-, medium-, and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among veterans affairs patients.","volume":"64","author":"Britt","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/cid\/ciw173","article-title":"Influence of minimum inhibitory concentration in clinical outcomes of Enterococcus faecium bacteremia treated with daptomycin: Is it time to change the breakpoint?","volume":"62","author":"Shukla","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.","volume":"47","author":"Longley","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/318717","article-title":"Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.","volume":"32","author":"Caballero-Granado","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s10096-014-2167-y","article-title":"Is a single positive blood culture for Enterococcus species representative of infection or contamination?","volume":"33","author":"Jindai","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1128\/JCM.42.7.2980-2987.2004","article-title":"Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.","volume":"42","author":"\u00d8vsteb\u00f8","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/01.inf.0000260253.22994.61","article-title":"High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease.","volume":"26","author":"Carrol","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0732-8893(03)00129-9","article-title":"A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF.","volume":"47","author":"van Haeften","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for Gram-positive infections.","volume":"46","author":"Tally","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin.","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.","volume":"47","author":"Dvorchik","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0091270004269562","article-title":"The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.","volume":"45","author":"Dvorchik","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1128\/AAC.06439-11","article-title":"Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic\/pharmacodynamic model with simulated endocardial vegetations.","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R40-20230728","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/AAC.45.2.454-459.2001","article-title":"Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.","volume":"45","author":"Akins","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R41-20230728","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/13543784.2013.766716","article-title":"Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: A phase I pharmacokinetic and pharmacodynamic study.","volume":"22","author":"Cai","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"R42-20230728","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0732-8893(87)90167-2","article-title":"Effect of antimicrobials on blood cultures in endocarditis.","volume":"8","author":"McKenzie","year":"1987","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R43-20230728","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0954-6111(99)90010-0","article-title":"Utility of blood cultures in community-acquired pneumonia requiring hospitalization: Influence of antibiotic treatment before admission.","volume":"93","author":"Glerant","year":"1999","journal-title":"Respir Med"},{"key":"R44-20230728","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jac\/dks469","article-title":"Twenty-five years of shared life with vancomycin-resistant enterococci: Is it time to divorce?","volume":"68","author":"Cattoir","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R45-20230728","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/jac\/dks181","article-title":"Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: Implication of sequence type for prognosis.","volume":"67","author":"Lu","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R46-20230728","doi-asserted-by":"crossref","first-page":"e115555","DOI":"10.1371\/journal.pone.0115555","article-title":"National surveillance on vancomycin-resistant Enterococcus faecium in Taiwan: Emergence and widespread of ST414 and a Tn1546-like element with simultaneous insertion of IS1251-like and IS1678.","volume":"9","author":"Kuo","year":"2014","journal-title":"PLoS One"},{"key":"R47-20230728","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1126\/science.113.2940.520","article-title":"Factors involved in blood clearance of bacteria.","volume":"113","author":"Stavitsky","year":"1951","journal-title":"Science"},{"key":"R48-20230728","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1164\/rccm.200509-1470OC","article-title":"Severe bacteremia results in a loss of hepatic bacterial clearance.","volume":"173","author":"Ashare","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R49-20230728","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1752-8062.2009.00122.x","article-title":"Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.","volume":"2","author":"Ashare","year":"2009","journal-title":"Clin Transl Sci"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003246-201810000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:04Z","timestamp":1786038424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003246-201810000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000003264","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}